Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Fresh Food

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1972966

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1972966

Commercial Aquaculture Vaccines Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global Commercial Aquaculture Vaccines Market is experiencing consistent growth as aquaculture producers increasingly prioritize disease prevention and fish health management. Aquaculture has become a vital component of the global food supply chain, providing a significant share of the seafood consumed worldwide. As fish farming operations expand to meet rising consumer demand, maintaining healthy aquatic stocks has become a critical challenge for producers.

Vaccination has emerged as one of the most effective and sustainable methods to control infectious diseases in aquaculture. Unlike antibiotics or chemical treatments, vaccines offer long-term protection against pathogens while minimizing environmental impact and reducing the risk of antimicrobial resistance. As a result, fish vaccination programs are being widely adopted across both developed and emerging aquaculture markets.

The growing emphasis on sustainable aquaculture practices, combined with technological advancements in biotechnology, is supporting the development of innovative vaccine solutions tailored to various fish species. Governments, regulatory agencies, and aquaculture producers are increasingly investing in disease prevention strategies to protect fish populations and ensure stable seafood production.

According to recent industry analysis, the Commercial Aquaculture Vaccines Market is expected to reach 457.4 billion in 2026 and grow to approximately 751.3 billion by 2033, progressing at a compound annual growth rate (CAGR) of 5.00% during the forecast period. This steady growth highlights the increasing importance of vaccination programs in the global aquaculture industry.

Market Insights

Aquaculture has become the fastest-growing food production sector in the world due to increasing global seafood consumption and the depletion of wild fish stocks. However, intensive fish farming practices often expose aquatic species to higher risks of infectious diseases. High stocking densities, environmental stress, and pathogen exposure can significantly affect fish health and productivity.

Commercial aquaculture vaccines help address these challenges by providing targeted immunity against various bacterial and viral diseases affecting farmed fish. These vaccines are formulated to stimulate the immune response of aquatic species, helping them resist infections and maintain healthy growth rates.

Advancements in biotechnology and molecular research have significantly improved vaccine formulations over the past decade. Modern aquaculture vaccines are becoming more effective, safer, and easier to administer. Researchers are also developing species-specific vaccines designed to protect fish populations commonly farmed in different regions, such as salmon, tilapia, trout, and carp.

The adoption of vaccination programs is particularly common in large-scale aquaculture operations where disease outbreaks can result in severe economic losses. By preventing infections before they occur, vaccines help fish farmers maintain consistent production levels and reduce operational risks.

Market Drivers

The growing global demand for seafood is one of the most important factors driving the Commercial Aquaculture Vaccines Market. With the global population increasing and consumers becoming more health conscious, fish and seafood products are gaining popularity due to their high protein content and nutritional value. As aquaculture production increases to meet this demand, the need for effective disease management solutions continues to rise.

Another significant driver is the increasing occurrence of infectious diseases in aquaculture environments. Pathogens can spread rapidly in aquatic systems, leading to large-scale mortality events that affect both production and profitability. Vaccination provides a reliable method to prevent such outbreaks and protect fish populations.

Regulatory restrictions on antibiotic usage are also accelerating the adoption of vaccines in aquaculture. Many governments and international health organizations are encouraging producers to reduce antibiotic use in food production due to concerns related to antimicrobial resistance. Vaccines serve as a sustainable and preventive alternative that aligns with global food safety standards.

Technological innovations in vaccine development are further contributing to market growth. Advances in recombinant DNA technology, molecular biology, and immunology are enabling the development of next-generation vaccines capable of targeting complex pathogens. Improved delivery systems are also making vaccination processes more efficient and cost-effective.

Business Opportunities

The Commercial Aquaculture Vaccines Market presents numerous opportunities for pharmaceutical companies, biotechnology firms, and aquaculture technology providers. As aquaculture production continues to expand worldwide, the demand for specialized vaccines tailored to specific species and environmental conditions is increasing.

Emerging aquaculture markets in Asia, Latin America, and parts of Africa offer substantial growth potential for vaccine manufacturers. Many of these regions are investing heavily in aquaculture infrastructure to strengthen food security and support economic development. Increased awareness about fish health management in these regions is expected to boost vaccine adoption.

Another promising area of opportunity lies in innovative vaccine delivery methods. Traditional injection-based vaccination can be labor-intensive, particularly in large fish populations. Oral and immersion vaccines are gaining attention as they simplify the vaccination process and reduce handling stress for fish. These technologies have the potential to significantly improve efficiency in commercial aquaculture operations.

Research collaborations between industry players, academic institutions, and government agencies are also fostering innovation in vaccine development. Such partnerships help accelerate the discovery of new vaccine technologies and support the commercialization of advanced aquaculture health solutions.

Regional Analysis

North America holds a notable share of the Commercial Aquaculture Vaccines Market due to its advanced aquaculture infrastructure and strong focus on animal health management. The presence of established pharmaceutical companies and ongoing research initiatives contributes to the development of innovative vaccines for aquaculture species.

Europe also represents a significant market for aquaculture vaccines, supported by strict regulations on antibiotic usage and strong emphasis on sustainable aquaculture practices. Countries with large salmon farming industries are particularly active in implementing vaccination programs to prevent bacterial and viral infections.

The Asia Pacific region is expected to witness the fastest market growth during the forecast period. Countries such as China, India, Vietnam, and Indonesia are among the largest aquaculture producers in the world. The rapid expansion of fish farming activities in these nations is generating strong demand for vaccines to ensure healthy fish stocks and improve production efficiency.

Latin America is emerging as an important aquaculture region, particularly due to the growth of salmon farming and marine aquaculture industries. Increasing investments in fish farming technologies and disease management strategies are supporting the expansion of the vaccine market in the region.

The Middle East & Africa region is gradually adopting modern aquaculture practices as governments focus on improving domestic seafood production and enhancing food security. Growing aquaculture projects in the region are expected to contribute to increased demand for fish vaccines in the coming years.

Key Players

  • Merck & Co.
  • Elanco Animal Health Incorporated
  • Phibro Animal Health Corporation
  • HIPRA
  • Zoetis Animal Healthcare
  • IDT Biologika
  • Tecnovax S.A.
  • AquaVet Health Inc/AQUAVET S.A.
  • Nisseiken Co., Ltd.
  • ICTYO, Virbac

Market Segmentation

By Vaccine Type

  • Attenuated
  • Inactivated
  • Subunit
  • DNA

By Pathogen

  • Virus
  • Bacteria

By Species

  • Tilapia
  • Salmon
  • Trout
  • Carp
  • Sea Bass
  • Bream
  • Turbot
  • Others

By Route of Administration

  • Intramuscular
  • Intraperitoneal
  • Oral
  • Immersion

By End User

  • Fish Veterinary Clinics
  • Fish Farming Companies
  • Aquatic Research Institutes

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Commercial Aquaculture Vaccines Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Commercial Aquaculture Vaccines Market Outlook, 2020-2033

  • 3.1. Global Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Attenuated
    • 3.1.2. Inactivated
    • 3.1.3. Subunit
    • 3.1.4. DNA
  • 3.2. Global Commercial Aquaculture Vaccines Market Outlook, by Pathogen, Value (US$ Bn), 2020-2033
    • 3.2.1. Virus
    • 3.2.2. Bacteria
  • 3.3. Global Commercial Aquaculture Vaccines Market Outlook, by Species, Value (US$ Bn), 2020-2033
    • 3.3.1. Tilapia
    • 3.3.2. Salmon
    • 3.3.3. Trout
    • 3.3.4. Carp
    • 3.3.5. Sea Bass
    • 3.3.6. Bream
    • 3.3.7. Turbot
    • 3.3.8. Others
  • 3.4. Global Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033
    • 3.4.1. Intramuscular
    • 3.4.2. Intraperitoneal
    • 3.4.3. Oral
    • 3.4.4. Immersion
  • 3.5. Global Commercial Aquaculture Vaccines Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.5.1. Fish Veterinary Clinics
    • 3.5.2. Fish Farming Companies
    • 3.5.3. Aquatic Research Institutes
  • 3.6. Global Commercial Aquaculture Vaccines Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.6.1. North America
    • 3.6.2. Europe
    • 3.6.3. Asia Pacific
    • 3.6.4. Latin America
    • 3.6.5. Middle East & Africa

4. North America Commercial Aquaculture Vaccines Market Outlook, 2020-2033

  • 4.1. North America Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Attenuated
    • 4.1.2. Inactivated
    • 4.1.3. Subunit
    • 4.1.4. DNA
  • 4.2. North America Commercial Aquaculture Vaccines Market Outlook, by Pathogen, Value (US$ Bn), 2020-2033
    • 4.2.1. Virus
    • 4.2.2. Bacteria
  • 4.3. North America Commercial Aquaculture Vaccines Market Outlook, by Species, Value (US$ Bn), 2020-2033
    • 4.3.1. Tilapia
    • 4.3.2. Salmon
    • 4.3.3. Trout
    • 4.3.4. Carp
    • 4.3.5. Sea Bass
    • 4.3.6. Bream
    • 4.3.7. Turbot
    • 4.3.8. Others
  • 4.4. North America Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033
    • 4.4.1. Intramuscular
    • 4.4.2. Intraperitoneal
    • 4.4.3. Oral
    • 4.4.4. Immersion
  • 4.5. North America Commercial Aquaculture Vaccines Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.5.1. Fish Veterinary Clinics
    • 4.5.2. Fish Farming Companies
    • 4.5.3. Aquatic Research Institutes
  • 4.6. North America Commercial Aquaculture Vaccines Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.6.1. U.S. Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 4.6.2. U.S. Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 4.6.3. U.S. Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 4.6.4. U.S. Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 4.6.5. U.S. Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 4.6.6. Canada Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 4.6.7. Canada Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 4.6.8. Canada Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 4.6.9. Canada Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 4.6.10. Canada Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
  • 4.7. BPS Analysis/Market Attractiveness Analysis

5. Europe Commercial Aquaculture Vaccines Market Outlook, 2020-2033

  • 5.1. Europe Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Attenuated
    • 5.1.2. Inactivated
    • 5.1.3. Subunit
    • 5.1.4. DNA
  • 5.2. Europe Commercial Aquaculture Vaccines Market Outlook, by Pathogen, Value (US$ Bn), 2020-2033
    • 5.2.1. Virus
    • 5.2.2. Bacteria
  • 5.3. Europe Commercial Aquaculture Vaccines Market Outlook, by Species, Value (US$ Bn), 2020-2033
    • 5.3.1. Tilapia
    • 5.3.2. Salmon
    • 5.3.3. Trout
    • 5.3.4. Carp
    • 5.3.5. Sea Bass
    • 5.3.6. Bream
    • 5.3.7. Turbot
    • 5.3.8. Others
  • 5.4. Europe Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033
    • 5.4.1. Intramuscular
    • 5.4.2. Intraperitoneal
    • 5.4.3. Oral
    • 5.4.4. Immersion
  • 5.5. Europe Commercial Aquaculture Vaccines Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.5.1. Fish Veterinary Clinics
    • 5.5.2. Fish Farming Companies
    • 5.5.3. Aquatic Research Institutes
  • 5.6. Europe Commercial Aquaculture Vaccines Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.6.1. Germany Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 5.6.2. Germany Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 5.6.3. Germany Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 5.6.4. Germany Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 5.6.5. Germany Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 5.6.6. Italy Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 5.6.7. Italy Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 5.6.8. Italy Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 5.6.9. Italy Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 5.6.10. Italy Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 5.6.11. France Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 5.6.12. France Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 5.6.13. France Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 5.6.14. France Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 5.6.15. France Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 5.6.16. U.K. Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 5.6.17. U.K. Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 5.6.18. U.K. Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 5.6.19. U.K. Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 5.6.20. U.K. Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 5.6.21. Spain Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 5.6.22. Spain Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 5.6.23. Spain Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 5.6.24. Spain Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 5.6.25. Spain Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 5.6.26. Russia Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 5.6.27. Russia Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 5.6.28. Russia Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 5.6.29. Russia Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 5.6.30. Russia Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 5.6.31. Rest of Europe Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 5.6.32. Rest of Europe Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 5.6.33. Rest of Europe Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 5.6.34. Rest of Europe Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 5.6.35. Rest of Europe Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
  • 5.7. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, 2020-2033

  • 6.1. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Attenuated
    • 6.1.2. Inactivated
    • 6.1.3. Subunit
    • 6.1.4. DNA
  • 6.2. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, by Pathogen, Value (US$ Bn), 2020-2033
    • 6.2.1. Virus
    • 6.2.2. Bacteria
  • 6.3. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, by Species, Value (US$ Bn), 2020-2033
    • 6.3.1. Tilapia
    • 6.3.2. Salmon
    • 6.3.3. Trout
    • 6.3.4. Carp
    • 6.3.5. Sea Bass
    • 6.3.6. Bream
    • 6.3.7. Turbot
    • 6.3.8. Others
  • 6.4. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033
    • 6.4.1. Intramuscular
    • 6.4.2. Intraperitoneal
    • 6.4.3. Oral
    • 6.4.4. Immersion
  • 6.5. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.5.1. Fish Veterinary Clinics
    • 6.5.2. Fish Farming Companies
    • 6.5.3. Aquatic Research Institutes
  • 6.6. Asia Pacific Commercial Aquaculture Vaccines Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.6.1. China Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 6.6.2. China Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 6.6.3. China Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 6.6.4. China Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 6.6.5. China Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 6.6.6. Japan Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 6.6.7. Japan Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 6.6.8. Japan Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 6.6.9. Japan Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 6.6.10. Japan Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 6.6.11. South Korea Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 6.6.12. South Korea Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 6.6.13. South Korea Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 6.6.14. South Korea Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 6.6.15. South Korea Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 6.6.16. India Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 6.6.17. India Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 6.6.18. India Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 6.6.19. India Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 6.6.20. India Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 6.6.21. Southeast Asia Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 6.6.22. Southeast Asia Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 6.6.23. Southeast Asia Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 6.6.24. Southeast Asia Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 6.6.25. Southeast Asia Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 6.6.26. Rest of SAO Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 6.6.27. Rest of SAO Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 6.6.28. Rest of SAO Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 6.6.29. Rest of SAO Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 6.6.30. Rest of SAO Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
  • 6.7. BPS Analysis/Market Attractiveness Analysis

7. Latin America Commercial Aquaculture Vaccines Market Outlook, 2020-2033

  • 7.1. Latin America Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Attenuated
    • 7.1.2. Inactivated
    • 7.1.3. Subunit
    • 7.1.4. DNA
  • 7.2. Latin America Commercial Aquaculture Vaccines Market Outlook, by Pathogen, Value (US$ Bn), 2020-2033
    • 7.2.1. Virus
    • 7.2.2. Bacteria
  • 7.3. Latin America Commercial Aquaculture Vaccines Market Outlook, by Species, Value (US$ Bn), 2020-2033
    • 7.3.1. Tilapia
    • 7.3.2. Salmon
    • 7.3.3. Trout
    • 7.3.4. Carp
    • 7.3.5. Sea Bass
    • 7.3.6. Bream
    • 7.3.7. Turbot
    • 7.3.8. Others
  • 7.4. Latin America Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033
    • 7.4.1. Intramuscular
    • 7.4.2. Intraperitoneal
    • 7.4.3. Oral
    • 7.4.4. Immersion
  • 7.5. Latin America Commercial Aquaculture Vaccines Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.5.1. Fish Veterinary Clinics
    • 7.5.2. Fish Farming Companies
    • 7.5.3. Aquatic Research Institutes
  • 7.6. Latin America Commercial Aquaculture Vaccines Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.6.1. Brazil Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 7.6.2. Brazil Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 7.6.3. Brazil Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 7.6.4. Brazil Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 7.6.5. Brazil Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 7.6.6. Mexico Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 7.6.7. Mexico Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 7.6.8. Mexico Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 7.6.9. Mexico Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 7.6.10. Mexico Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 7.6.11. Argentina Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 7.6.12. Argentina Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 7.6.13. Argentina Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 7.6.14. Argentina Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 7.6.15. Argentina Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 7.6.16. Rest of LATAM Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 7.6.17. Rest of LATAM Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 7.6.18. Rest of LATAM Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 7.6.19. Rest of LATAM Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 7.6.20. Rest of LATAM Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
  • 7.7. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Attenuated
    • 8.1.2. Inactivated
    • 8.1.3. Subunit
    • 8.1.4. DNA
  • 8.2. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, by Pathogen, Value (US$ Bn), 2020-2033
    • 8.2.1. Virus
    • 8.2.2. Bacteria
  • 8.3. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, by Species, Value (US$ Bn), 2020-2033
    • 8.3.1. Tilapia
    • 8.3.2. Salmon
    • 8.3.3. Trout
    • 8.3.4. Carp
    • 8.3.5. Sea Bass
    • 8.3.6. Bream
    • 8.3.7. Turbot
    • 8.3.8. Others
  • 8.4. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033
    • 8.4.1. Intramuscular
    • 8.4.2. Intraperitoneal
    • 8.4.3. Oral
    • 8.4.4. Immersion
  • 8.5. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.5.1. Fish Veterinary Clinics
    • 8.5.2. Fish Farming Companies
    • 8.5.3. Aquatic Research Institutes
  • 8.6. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.6.1. GCC Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 8.6.2. GCC Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 8.6.3. GCC Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 8.6.4. GCC Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 8.6.5. GCC Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 8.6.6. South Africa Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 8.6.7. South Africa Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 8.6.8. South Africa Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 8.6.9. South Africa Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 8.6.10. South Africa Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 8.6.11. Egypt Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 8.6.12. Egypt Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 8.6.13. Egypt Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 8.6.14. Egypt Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 8.6.15. Egypt Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 8.6.16. Nigeria Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 8.6.17. Nigeria Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 8.6.18. Nigeria Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 8.6.19. Nigeria Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 8.6.20. Nigeria Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
    • 8.6.21. Rest of Middle East Commercial Aquaculture Vaccines Market Outlook, by Vaccine Type, 2020-2033
    • 8.6.22. Rest of Middle East Commercial Aquaculture Vaccines Market Outlook, by Pathogen, 2020-2033
    • 8.6.23. Rest of Middle East Commercial Aquaculture Vaccines Market Outlook, by Species, 2020-2033
    • 8.6.24. Rest of Middle East Commercial Aquaculture Vaccines Market Outlook, by Route of Administration, 2020-2033
    • 8.6.25. Rest of Middle East Commercial Aquaculture Vaccines Market Outlook, by End User, 2020-2033
  • 8.7. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Merck & Co.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Elanco Animal Health Incorporated
    • 9.4.3. Phibro Animal Health Corporation
    • 9.4.4. HIPRA
    • 9.4.5. Zoetis Animal Healthcare
    • 9.4.6. IDT Biologika
    • 9.4.7. Tecnovax S.A.
    • 9.4.8. AquaVet Health Inc/AQUAVET S.A.
    • 9.4.9. Nisseiken Co., Ltd.
    • 9.4.10. ICTYO, Virbac

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!